ClinicalTrials.Veeva

Menu

Resistance Exercise and Low-Intensity Physical Activity Breaks in Sedentary Time to Improve Muscle and Cardiometabolic Health (REALPA)

L

Louisiana State University and A&M College

Status

Completed

Conditions

Aging
Diabetes Mellitus
Insulin Resistance
Cardiovascular Diseases
Sarcopenia
Disability Physical

Treatments

Behavioral: Exercise Intervention

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT03771417
2018-026
R21AG058181 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

What are the effects of resistance exercise (RE) alone or RE plus low intensity physical activity (LPA) breaks in sedentary time (ST) on skeletal muscle health in older adults?

What are the effects of resistance exercise (RE) alone or RE plus low intensity physical activity (LPA) breaks in sedentary time (ST) on skeletal cardiometabolic health in older adults?

Full description

Although awareness of the detrimental impact that sedentary behavior has on skeletal muscle and cardiometabolic health has increased over the last 20 years, more than 60% of older adults remain sedentary for greater than 8 hours per day. Moreover, 80% to 90% of adults 60 years of age or older do not meet the current public health guidelines for aerobic exercise (AE) or resistance exercise (RE) based physical activity (PA). Collectively, these adverse health behaviors contribute to the development of multiple chronic medical conditions commonly afflicting older adults, including type 2 diabetes, cardiovascular disease, sarco/dynapenia, frailty, and premature mortality. Emerging evidence suggests that breaking up sedentary time with light intensity PA (LPA) improves muscle and cardiometabolic health. Recent data also suggest that RE combined with moderate intensity AE effectively improves muscle and cardiometabolic health in older adults. However, the impact that RE combined with LPA breaks in sedentary time has on muscle and cardiometabolic health in older adults remains unknown. The overall objective of this pilot study is to determine the effect of 16 weeks of RE alone or RE combined with LPA breaks in sedentary time on muscle and cardiometabolic health.

Enrollment

24 patients

Sex

All

Ages

65 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Are capable and willing to give written informed consent, and understand exclusion criteria

  2. 65-80 years of age inclusive

  3. Body Mass Index (BMI) between 18.5-34.9 kg/m2, inclusive

  4. Physically inactive determined by self-report

  5. Stable medical therapy for allowable medications for 30 days defined as:

    1. No addition or removal of a medication
    2. No change in dosage of a medication
  6. Having no life-threatening conditions or diseases

  7. Willing to allow researchers to use data, bio-specimens (blood and muscle tissue), and images (e.g., magnetic resonance imaging) for research purposes after study participation is completed

  8. At least 2 weeks post-completion of the COVID19 vaccine regimen. a. Acceptable proof of vaccine includes a completed vaccine card and/or letter from a healthcare provider indicating the date that the COVID19 vaccine was completed.

Exclusion criteria

  1. Nursing home resident

  2. Physically Active:

    a. > 100 min/wk of moderate OR > 50 min/wk vigorous intensity PA

  3. Saint Louis University Mental State (SLUMS) score < 21

  4. Evidence or self-report history of deep vein thrombosis, pulmonary embolism, cardiovascular, peripheral vascular, cerebral vascular, pulmonary, or renal disease

  5. Evidence or self-report history of type 1 or 2 diabetes mellitus

  6. Evidence or self-report history of a bleeding disorder

  7. Evidence or self-report history of recurrent vasovagal episodes

  8. Evidence or self-report history of severe depression, Schizophrenia, bipolar disease

  9. Evidence or self-report history of mobility disability requiring a walker, wheel chair, or inability to walk across a small room.

  10. Evidence or self-report history of orthopedic limitations that would preclude them from participation in a dynamic exercise program

  11. Evidence or self-report history of severe arthritis (either osteoarthritis or rheumatoid arthritis) that would preclude them from participation in a dynamic exercise program

  12. Evidence or self-report of history untreated thyroid dysfunction.

  13. Weight loss of > 10% in the last 3 months prior to screening

  14. History of weight loss surgery.

  15. Use of medications known to influence study outcomes, such as:

    1. Insulin
    2. Oral antidiabetic medications (e.g., metformin)
    3. Corticosteroids
    4. Beta-blockers

    c. Anticoagulants

  16. Allergy to lidocaine

  17. Active smoking

  18. Current consumption of > 14 alcoholic drinks per week based on self-report

  19. Regular participation in resistance or aerobic exercise training within 3 months of initial screening

  20. Absolute Contraindication to Exercise as Defined by the American College of Sports Medicine,16 including:

    1. Resting diastolic blood pressure > 100 mm Hg
    2. Resting systolic blood pressure > 180 mm Hg
    3. Resting heart rate > 100 beats per min
  21. Having a body weight greater than 440 pounds

  22. Having medical implants such as a pacemaker or metal joint replacements

  23. Having tattoos or permanent makeup completed <30 days prior to the visit

  24. Recent (past 3 months) cancer diagnosis, undergoing immunotherapy, taking immune suppressants

  25. Presence of allergies or infections requiring antibiotics within the past 14 days

  26. Recent (past 3 months) major surgery on the abdomen, pelvis, or lower extremities

  27. Any other condition that in the judgement of the Principal Investigator and/or the Medical Director of this protocol may interfere with study participation and adherence to the protocol.

  28. Evidence or self-report history of severe depression in the last 5 years.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

24 participants in 3 patient groups

Resistance Exercise
Experimental group
Description:
Exercise Intervention: Participants will be asked to complete supervised resistance exercise 2 days per week.
Treatment:
Behavioral: Exercise Intervention
RE plus Low Intensity Physical Activity
Experimental group
Description:
Exercise Intervention: Participants will be asked to complete supervised resistance exercise 2 days per week and regular unsupervised low intensity physical activity breaks in sedentary time 5 days per week \[6x10 min breaks/d at 2 metabolic equivalents (METS) or \~30-40% peak oxygen consumption (VO2 peak), \~500 kcal/wk above resting metabolism\].
Treatment:
Behavioral: Exercise Intervention
RE plus Moderate IntensityExercise
Active Comparator group
Description:
Exercise Intervention: Participants will be asked to complete supervised RE 2 days per week and supervised calorically matched moderate intensity physical activity 3 days per week (50 min/session at 4 METS (\~60-75% VO2 peak), \~500 kcal/week above resting metabolism).
Treatment:
Behavioral: Exercise Intervention

Trial documents
1

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems